James P. Allison | |
---|---|
Born | James Patrick Allison[1] August 7, 1948 |
Nationality | American |
Alma mater | University of Texas, Austin |
Known for | Cancer immunotherapy |
Spouse | Padmanee Sharma[2] |
Awards | Breakthrough Prize in Life Sciences (2014) Tang Prize (2014)[3] Louisa Gross Horwitz Prize (2014) Harvey Prize (2014) Gairdner Foundation International Award (2014) Lasker-DeBakey Clinical Medical Research Award (2015)[4] Wolf Prize (2017) Balzan Prize (2017, jointly with Robert D. Schreiber) The Sjöberg Prize (2017, jointly with Anthony R. Hunter) King Faisal International Prize (2018) Albany Medical Center Prize (2018) Dr. Paul Janssen Award for Biomedical Research (2018)[5] Nobel Prize in Physiology or Medicine (2018) |
Scientific career | |
Fields | Immunology |
Institutions | M. D. Anderson Cancer Center Weill Cornell Medicine University of California, Berkeley |
Doctoral advisor | G. Barrie Kitto |
James Patrick Allison (born August 7, 1948) is an American immunologist. He is a professor and chair of Immunology and executive director of immunotherapy platform at the M. D. Anderson Cancer Center. His discoveries have led to new cancer treatments for the deadliest cancers. He is also the director of the Cancer Research Institute (CRI). He is thought to be the first person to isolate the T-cell antigen receptor complex protein.[6]
In 2018, he was awarded the Nobel Prize in Physiology or Medicine along with Tasuku Honjo.[7][8]